Therapeutic Advances in Vaccines
Overview
Therapeutic Advances in Vaccines is a scientific journal, published by Sage Publications since 2013 in English. The journal's country of origin is United Kingdom.
Details
Details
Abbr.
Ther Adv Vaccines
Publisher
Sage Publications
Start
2013
End
2017
Frequency
Bimonthly
p-ISSN
2051-0136
e-ISSN
2051-0144
Country
United Kingdom
Language
English
Recent Articles
1.
Chacon-Cruz E, Arellano-Estrada J, Lopatynsky-Reyes E, Alvelais-Palacios J, Becka C
Ther Adv Vaccines
. 2017 Dec;
5(4-5):103-107.
PMID: 29201375
Objectives: Vaccination against tuberculosis with live-attenuated Bacillus Calmette-Guérin (BCG) is widely used even though its effectiveness is controversial. BCG-lymphadenitis (BCG-LA) is its most common complication. Some studies have proposed that...
2.
Askarizadeh A, Jaafari M, Khamesipour A, Badiee A
Ther Adv Vaccines
. 2017 Dec;
5(4-5):85-101.
PMID: 29201374
Leishmaniasis is a parasitic disease that ranges in severity from skin lesions to fatality. Since long-lasting protection is induced upon recovery from cutaneous leishmaniasis, development of an effective vaccine is...
3.
Smola S, Trimble C, Stern P
Ther Adv Vaccines
. 2017 Aug;
5(3):69-82.
PMID: 28794879
It is now recognized that the immune system can be a key component of restraint and control during the neoplastic process. Human papillomavirus (HPV)-associated cancers of the anogenital tract and...
4.
5.
Chyu K, Dimayuga P, Shah P
Ther Adv Vaccines
. 2017 May;
5(2):39-47.
PMID: 28515939
Substantial data from experimental and clinical investigation support the role of immune-mediated mechanisms in atherogenesis, with immune systems responding to many endogenous and exogenous antigens that play either proatherogenic or...
6.
Jakob V, Brunner L, Barnier-Quer C, Blust M, Collin N, Carter L, et al.
Ther Adv Vaccines
. 2017 May;
5(2):31-38.
PMID: 28515938
Objectives: Several vaccine adjuvants comprise complex nano- or micro-particle formulations, such as oil-in-water emulsions. In order to characterize interactions and compatibility of oil-in-water emulsion adjuvants with protein antigens in vaccines,...
7.
Antoniazzi S, Carnovale C, Sessa A, Gentili M, Matacena M, Punginelli M, et al.
Ther Adv Vaccines
. 2017 Mar;
5(1):25-27.
PMID: 28344806
No abstract available.
8.
Wiedinger K, Pinho D, Bitsaktsis C
Ther Adv Vaccines
. 2017 Mar;
5(1):15-24.
PMID: 28344805
Backgound: The introduction of the pneumococcal conjugate and polysaccharide vaccines have been valuable tools for combating invasive pneumococcal infection in children and healthy adults. Despite the available vaccination strategies, pneumococcal...
9.
Banzhoff A
Ther Adv Vaccines
. 2017 Mar;
5(1):3-14.
PMID: 28344804
Meningococcal disease is rare, easily misdiagnosed, and potentially deadly. Diagnosis in the early stages is difficult and the disease often progresses extremely rapidly. In North America, the incidence of invasive...
10.
Ther Adv Vaccines
. 2016 Aug;
4(1-2):32.
PMID: 27551430
[This corrects the article DOI: 10.1177/2051013615599151.].